Cyclo-oxygenase type 2-dependent prostaglandin E2 secretion is involved in retrovirus-induced T-cell dysfunction in mice

Biochemical Journal

Volumn 384, Issue 3, 2004, Pages 469-476

  Rahmouni, Souad ^a   Aandahl, Einar Martin ^b   Nayjib, Btissam ^a   Zeddou, Mustapha ^a   Giannini, Sandra ^a   Verlaet, Myriam ^a   Greimers, Roland ^a   Boniver, Jaques ^a   Tasken, Kjetil ^b   Moutschen, Michel ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

cAMP; Cyclo oxygenase type 2; Immunodeficiency; Prostaglandin E2; Retroviral infection; T cell

Indexed keywords

ACTIVATION ANALYSIS; CELLS; DISEASE CONTROL; FUNCTIONS; IMMUNOLOGY; LIVING SYSTEMS STUDIES; VIRUSES;

B-CELLS; HYPERACTIVATION; IMMUNODEFICIENCY; T-CELLS;

ENZYMES;

CD11B ANTIGEN; CYCLIC AMP; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; G PROTEIN COUPLED RECEPTOR; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CLONAL ANERGY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNE DEFICIENCY; IMMUNOPATHOLOGY; LYMPH NODE; LYMPHOPROLIFERATIVE DISEASE; MOUSE; MOUSE STRAIN; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION; RODENT DISEASE; T LYMPHOCYTE; UPREGULATION;

ANIMALS; ANTIGENS, CD11B; B-LYMPHOCYTES; CLONAL ANERGY; CYCLIC AMP; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ENZYME INDUCTION; HIV; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RADIATION LEUKEMIA VIRUS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

ANIMALIA; MURINAE; MURINE LEUKEMIA VIRUS; RNA VIRUSES; RODENTIA; UNIDENTIFIED RETROVIRUS;

EID: 19944381855     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20031859     Document Type: Article

References (39)

1. Aziz, D. C., Hanna, Z. and Jolicoeur, P. (1989) Severe immunodeficiency disease induced by a defective murine leukaemia virus. Nature (London) 338, 505-508
2. Mosier, D. E., Yetter, R. A. and Morse, III, H. C. (1987) Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). J. Exp. Med. 165,1737-1742
3. Yetter, R. A., Buller, R. M., Lee, J. S., Elkins, K. L., Mosier, D. E., Fredrickson, T. N. and Morse, III, H. C. (1988) CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J. Exp. Med. 168, 623-635
4. Cerny, A., Hugin, A. W., Hardy, R. R., Hayakawa, K., Zinkernagel, R. M., Makino, M. and Morse, III, H. C. (1990) B cells are required for induction of T cell abnormalities in a murine retrovirus-induced immunodeficiency syndrome. J. Exp. Med. 171, 315-320
5. Mosier, D. E., Yetter, R. A. and Morse, III, H. C. (1985) Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice. J. Exp. Med. 161, 766-784
6. Cerny, A., Hugin, A. W., Holmes, K. L. and Morse, III, H. C. (1990) CD4+ T cells in murine acquired immunodeficiency syndrome: evidence for an intrinsic defect in the proliferative response to soluble antigen. Eur. J. Immunol. 20, 1577-1581
7. Klinman, D. M. and Morse, III, H. C. (1989) Characteristics of B cell proliferation and activation in murine AIDS, J. Immunol. 142, 1144-1149
8. Muralidhar, G., Koch, S., Haas, M. and Swain, S. L. (1992) CD4T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy. J. Exp., Med. 175, 1589-1599
9. Green, K. A., Crassi, K. M, Laman, J. D., Schoneveld, A., Strawbridge, R. R., Foy, T. M., Noelle, R. J. and Green, W. R. (1996) Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice. J. Virol. 70, 2569-2575
10. De Leval, L., Colombi, S., Debrus, S., Demoitie, M. A., Greimers, R., Linsley, P., Moutschen, M. and Boniver, J. (1998) CD28-B7 costimulatory blockade by CTLA4lg delays the development of retrovirus-induced murine AIDS. J. Virol. 72, 5285-5290
11. De Leval, L., Debrus, S., Lane, P., Boniver, J. and Moutschen, M. (1999) Mice transgenic for a soluble form of murine cytotoxic T lymphocyte antigen 4 are refractory to murine acquired immune deficiency syndrome development, Immunology 98, 630-638
12. Makino, M., Yoshimatsu, K., Azuma, M., Okada, Y., Hitoshi, Y, Yagita, H., Takatsu, K. and Komuro, K. (1995) Rapid development of murine AIDS is dependent of signals provided by CD54 and CD11a. J. Immunol. 155, 974-981
13. Simard, C., Huang, M. and Jolicoeur, P. (1994) Murine AIDS is initiated in the lymph nodes draining the site of inoculation, and the infected B cells influence T cells located at distance, in noninfected organs. J. Virol. 68, 1903-1912
14. Giese, N. A., Giese, T. and Morse, III, H. C. (1994) Murine AIDS is an antigen-driven disease: requirements for major histocompatibility complex class II expression and CD4+T cells. J. Virol. 68, 5819-5824
15. Harris, D. P, Koch, S., Mullen, L. M. and Swain, S. L. (2001) B cell immunodeficiency fails to develop in CD4-deficient mice infected with BM5: murine AIDS as a multistep disease. J. Immunol. 166, 6041-6049
16. Doyon, L., Simard, C., Sekaly, R. P. and Jolicoeur, P. (1996) Evidence that the murine AIDS defective virus does not encode a superantigen. J. Virol. 70, 1-9
17. Koch, S., Muralidhar, G. and Swain, S. L. (1994) Both naive and memory CD4 T cell subsets become anergic during MAIDS and each subset can sustain disease. J. Immunol. 152, 5548-5556
18. Rahmouni, S., Aandahl, E. M., Trebak, M., Boniver, J., Tasken, K. and Moutschen, M. (2001) Increased cAMP levels and protein kinase (PKA) type I activation in CD4+ T cells and B cells contribute to retrovirus-induced immunodeficiency of mice (MAIDS): a useful in vivo model for drug testing. FASEB J. 15, 1466-1468
19. Aandahl, E. M., Moretto, W. J., Haslett, P. A., Vang, T., Bryn, T., Tasken, K. and Nixon, D. F. (2002) Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I. J. Immunol. 169, 802-808
20. Vang, T., Torgersen, K. M., Sundvold, V., Saxena, M., Levy, F O., Skalhegg, B. S., Hansson, V., Mustelin, T. and Tasken, K. (2001) Activation of the COOH-terminal Src kinase (Csk) bycAMP-dependent protein kinase inhibits signaling through the T cell receptor. J. Exp. Med. 193, 497-507
21. Aandahl, E. M., Aukrust, P., Skalhegg, B. S., Muller, F., Froland, S. S., Hansson, V. and Tasken, K. (1998) Protein kinase A type 1 antagonist restores immune responses of T cells from HIV-infected patients. FASEB J. 12, 855-862
22. Aandahl, E. M., Aukrust, P., Muller, F., Hansson, V., Tasken, K. and Froland, S. S. (1999) Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART. AIDS 13, F109-F114
23. Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A. and Vane, J. R. (1999) Nonsteroid drug selectivites for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc. Natl. Acad. Sci. U.S.A. 96, 7563-7568
24. Aukrust, P., Aandahl, E. M., Skalhegg, B. S., Nordoy, I., Hansson, V., Tasken, K., Froland, S. S. and Muller, F. (1999) Increased activation of protein kinase A type I contributes to the T cell deficiency in common variable immunodeficiency. J. Immunol. 162, 1178-1185
25. Breyer, R. M., Bagdassarian, C. K., Myers, S. A. and Breyer, M. D. (2001) Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41, 661-690
26. Vang, T., Abrahamsen, H., Myklebust, S., Horejsi, V. and Tasken, K. (2003) Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase a inhibits T cell receptor signaling. J. Biol. Chem. 278, 17597-17600
27. Crofford, L. J. (1997) COX-1 and COX-2 tissue expression: implications and predictions. J. Rheumatol. 24 (Suppl.49), 15-19
28. Pablos, J. L., Santiago, B., Carreira, P. E., Galindo, M. and Gomez-Reino, J. J. (1999) Cyclooxygenase-1 and -2 are expressed by human T cells. Clin. Exp. Immunol. 115, 86-90
29. de Gregorio, R., Iniguez, M. A., Fresno, M. and Alemany, S, (2001) Cot kinase induces cyclooxygenase-2 expression in T cells through activation of the nuclear factor of activated T cells. J. Biol. Chem. 276, 27003-27009
30. Roos, M. T., Miedema, F., Koot, M., Tersmette, M., Schaasberg, W. P., Coutinho, R. A. and Schellekens, P. T. (1995) T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J. Infect. Dis. 171, 531-536
31. Shearer, G. M. and Clerici, M. (1991) Early T-helper cell defects in HIV infection. AIDS 5, 245-253
32. Nokta, M. A. and Pollard, R. B. (1992) Human immunodeficiency virus replication: modulation by cellular levels of cAMP AIDS Res. Hum. Retroviruses 8, 1255-1261
33. Nokta, M. A., Hassan, M. I., Loesch, K. A, and Pollard, R. B. (1995) HIV-induced TNF-alpha regulates arachidonic acid and PGE2 release from HIV-infected mononuclear phagocytes. Virology 208, 590-600
34. Foley, P., Kazazi, F., Biti, R., Sorrell, T. C. and Cunningham, A. L (1992) HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids. Immunology 75, 391-397
35. Muto, S., Vetvicka, V. and Ross, G, D. (1993) CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents. J. Clin. Immunol. 13, 175-184
36. Wagner, C., Hansch, G. M., Stegmaier, S., Denefleh, B., Hug, F. and Schoels, M. (2001) The complement receptor 3, CR3 (CD11b/CD18), on T lymphocytes: activation-dependent up-regulation and regulatory function. Eur. J. Immunol. 31, 1173-1180
37. Huang, M. and Jolicoeur, P. (1994) Myristylation of Pr60gag of the murine AIDS-defective virus is required to induce disease and notably for the expansion of its target cells. J. Virol. 68, 5648-5655
38. Dupraz, P., Rebai, N., Klein, S. J., Beaulieu, N. and Jolicoeur, P. (1997) The murine AIDS virus Gag precursor protein binds to the SH3 domain of c-Abl. J. Virol. 71, 2615-2620
39. Nataraj, C., Thomas, D. W., Tilley, S. L., Nguyen, M. T., Mannon, R., Koller, B. H. and Coffman, T. M. (2001) Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J. Clin. Invest. 108, 1229-1235